PGFC
ASTX

Peapack-Gladstone Financial Corp’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-50,000
Closed -$425K – 290
2013
Q3 		$425K Hold
50,000
– – 0.04% 204
2013
Q2 		$206K Buy
+50,000
New +$269K 0.02% 275

Peapack-Gladstone Financial Corp's ASTX Position: Q4 2013 in Review

Peapack-Gladstone Financial Corp sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 50,000 shares — an estimated $425K sold.

Peapack-Gladstone Financial Corp first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $425K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Peapack-Gladstone Financial Corp reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Peapack-Gladstone Financial Corp sold 50,000 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $425K.
  • Peapack-Gladstone Financial Corp first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Peapack-Gladstone Financial Corp's ASTEX PHARMACEUTICALS, INC COM position peaked at $425K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q4 2013, filed 13 Feb 2014.